Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Molecular Biomarkers Predicting Early Development of Endometrial Carcinoma: A Pilot Study

NCT05273099 is registered in ClinicalTrials.gov with Università degli Studi di Ferrara as lead sponsor.

NCT NCT05273099
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05273099 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Molecular Biomarkers Predicting Early Development of Endometrial Carcinoma: A Pilot Study
Lead sponsor
Università degli Studi di Ferrara
Phase
Observational
Overall status
Unknown status
Start date
March 1, 2022
Completion date
December 31, 2023
Enrollment
8 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer of endometrium